Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded cytochrome c oxidase II pseudogene 30 (MTCO2P30) is classified as a pseudogene in the human genome. Located on chromosome 5, MTCO2P30 shares homology with the functional MT-CO2 gene but contains mutations and/or truncations that prevent it from producing a functional protein product[1][5]. Pseudogenes like MTCO2P30 are considered inactive remnants of once-functional genes; while some pseudogenes can affect gene expression via non-coding RNA mechanisms or through competing endogenous RNA effects, there is no evidence that MTCO2P30 itself has such function[9]. It is not involved in mitochondrial electron transport and has no known role in disease, biomarker use, or drug interaction. It should not be considered a receptor, enzyme, transporter, or any canonical therapeutic target. If you require structured information on the functional MT-CO2 gene, refer instead to Mitochondrially encoded cytochrome c oxidase II (MT-CO2), which is a bona fide enzyme and therapeutic biomarker involved in mitochondrial respiratory complex IV[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded cytochrome c oxidase II pseudogene 30 (MTCO2P30).